Pharmaceuticals/Biotech
Search documents
Zoetis Remains A Strong Buy Following Market Overreaction To Q3 Earnings (NYSE:ZTS)
Seeking Alpha· 2025-11-06 14:36
Zoetis Inc. ( ZTS ) is a pharmaceutical/biotech company that specializes in developing and commercializing various treatments for animals. They were founded in 1952 and are headquartered in Parsippany, NJ. The company IPO’d in 2013 after beingI have been investing in the stock market since I was 17 years old, and over the 25+ years since I have learned the joy of compounding, the value of dividend reinvesting, and the principle that patient investing through good times and bad brings the greatest rewards. I ...
Zoetis Remains A Strong Buy Following Market Overreaction To Q3 Earnings
Seeking Alpha· 2025-11-06 14:36
Core Insights - Zoetis Inc. is a pharmaceutical and biotech company focused on developing and commercializing treatments for animals, founded in 1952 and headquartered in Parsippany, NJ [1] - The company went public in 2013, indicating a significant milestone in its growth trajectory [1] Company Overview - Zoetis specializes in animal health products, which positions it uniquely within the pharmaceutical sector [1] - The company has a long history and has established itself as a leader in the animal health market [1] Investment Perspective - The article reflects a positive sentiment towards long-term investment strategies, emphasizing the importance of high-quality assets and the potential for high-risk, high-reward opportunities [1] - The author advocates for a patient investment approach, suggesting that this can yield substantial rewards over time [1]